Bank of New York Mellon’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-25,126
| Closed | -$7.49K | – | 4461 |
|
|
2023
Q2 | $7.49K | Sell |
25,126
-221,679
| -90% | -$66.1K | ﹤0.01% | 4345 |
|
|
2023
Q1 | $107K | Buy |
246,805
+7,201
| +3% | +$3.11K | ﹤0.01% | 4063 |
|
|
2022
Q4 | $283K | Buy |
239,604
+26,275
| +12% | +$31K | ﹤0.01% | 3819 |
|
|
2022
Q3 | $495K | Buy |
213,329
+164,893
| +340% | +$383K | ﹤0.01% | 3565 |
|
|
2022
Q2 | $107K | Buy |
48,436
+23,028
| +91% | +$50.9K | ﹤0.01% | 4212 |
|
|
2022
Q1 | $245K | Buy |
+25,408
| New | +$245K | ﹤0.01% | 4133 |
|